| Abstrakt: |
In dogs, inflammatory bowel disease (IBD) is a well-defined form of intestinal disease. Most cases are associated with lymphangiectasia. A 2-year-old, American Staffordshire Terrier male dog, presented with progressive diarrhea for more than 3 months. Clinical findings, laboratory findings, ultrasound images of the dog and also, histopathological evaluation of punch biopsy samples from the intestines were compatible with IBD and lymphangiectasia. The treatment of the dog was started with the treatment protocol containing octreotide (10 μg/dog per day, BID, sc.) and tranexamic acid (10 mg/kg, BID, im.) which was used for the first time in dogs with IBD and lymphangiectasia. Fecal consistency and defecation frequency returned to normal on the 15th day, also at the end of the first month of therapy hypoalbuminemia began to normalize, ascites completely disappeared and the thickness of the mucosal layer began to normalize, and the patient began to gain weight. In the controls performed at the end of the second month, it was determined that the patient's clinical signs and all laboratory results improved. To our knowledge, these results suggest that the combination of octreotide and tranexamic acid can effectively and without any side effects be used for the treatment of IBD in dogs for the first time. This case report, it is aimed to present a successful treatment method using octreotide and tranexamic acid in a dog with intestinal lymphangiectasia related to IBD and to raise awareness among veterinarians in patients with similar clinical findings. [ABSTRACT FROM AUTHOR] |
